Author: admin

  • Iran protesters tell of brutal police response as regime lashes out | Iran

    Iran protesters tell of brutal police response as regime lashes out | Iran

    Demonstrators have continued to take to the streets of Iran, defying an escalating crackdown by authorities against the growing protest movement.

    An internet shutdown imposed by the authorities on Thursday has largely cut the protesters off from…

    Continue Reading

  • ‘Harry Potter’ star Katie Leung recalls discriminatory remarks from fans

    ‘Harry Potter’ star Katie Leung recalls discriminatory remarks from fans

    ‘Harry Potter’ star Katie Leung recalls discriminatory remarks from fans

    Katie Leung reflected on the hostile reception she faced in the wake of her casting in the Harry Potter films and the toll it had taken on her…

    Continue Reading

  • Oceanside Running Club Association’s Learn to Run program starts Jan. 29

    Oceanside Running Club Association’s Learn to Run program starts Jan. 29

    Oceanside Running Club Association’s Learn to Run program starts Jan. 29

    Published 5:35 am Saturday, January 10, 2026

    Continue Reading

  • Samsung Confirms New Options For Android Users After Gmail Issues – Forbes

    1. Samsung Confirms New Options For Android Users After Gmail Issues  Forbes
    2. Exclusive: Samsung to double AI mobile devices to 800 million units this year  Reuters
    3. Samsung Unveils World’s First 130-Inch Micro RGB TV Featuring Next-Generation Color…

    Continue Reading

  • Woehrer, A., Bauchet, L. & Barnholtz-Sloan, J. S. Glioblastoma survival: Has it improved? Evidence from population-based studies. Curr. Opin. Neurol. 27, 666–674. https://doi.org/10.1097/wco.0000000000000144 (2014).

    Google Scholar 

  • Kan, L. K. et al. Potential biomarkers and challenges in glioma diagnosis, therapy and prognosis. BMJ Neurol. Open 2, e000069. https://doi.org/10.1136/bmjno-2020-000069 (2020).

    Google Scholar 

  • Stupp, R. et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352, 987–996. https://doi.org/10.1056/NEJMoa043330 (2005).

    Google Scholar 

  • Friedman, H. S. et al. Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J. Clin. Oncol. 27, 4733–4740. https://doi.org/10.1200/jco.2008.19.8721 (2009).

    Google Scholar 

  • Kreisl, T. N. et al. Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma. J. Clin. Oncol. 27, 740–745. https://doi.org/10.1200/jco.2008.16.3055 (2009).

    Google Scholar 

  • Cohen, M. H., Shen, Y. L., Keegan, P. & Pazdur, R. FDA drug approval summary: Bevacizumab (Avastin) as treatment of recurrent glioblastoma multiforme. Oncologist 14, 1131–1138. https://doi.org/10.1634/theoncologist.2009-0121 (2009).

    Google Scholar 

  • Ferrara, N., Hillan, K. J., Gerber, H.-P. & Novotny, W. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat. Rev. Drug Discov. 3, 391–400. https://doi.org/10.1038/nrd1381 (2004).

    Google Scholar 

  • Chinot, O. L. et al. Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. N. Engl. J. Med. 370, 709–722. https://doi.org/10.1056/NEJMoa1308345 (2014).

    Google Scholar 

  • Gilbert, M. R. et al. A randomized trial of bevacizumab for newly diagnosed glioblastoma. N. Engl. J. Med. 370, 699–708. https://doi.org/10.1056/NEJMoa1308573 (2014).

    Google Scholar 

  • Schmainda, K. M. et al. Value of dynamic contrast perfusion MRI to predict early response to bevacizumab in newly diagnosed glioblastoma: Results from ACRIN 6686 multicenter trial. Neuro Oncol. 23, 314–323. https://doi.org/10.1093/neuonc/noaa167 (2021).

    Google Scholar 

  • Xu, L. et al. COX-2 inhibition potentiates antiangiogenic cancer therapy and prevents metastasis in preclinical models. Sci. Transl. Med. 6, 242ra284-242ra284 (2014).

    Google Scholar 

  • Macarulla, T. et al. Atezolizumab plus chemotherapy with or without bevacizumab in advanced biliary tract cancer: Clinical and biomarker data from the randomized phase II IMbrave151 trial. J. Clin. Oncol. 43, 545–557 (2024).

    Google Scholar 

  • Loureiro, L. V. M. et al. The immunohistochemical landscape of the VEGF family and its receptors in glioblastomas. Surg. Exp. Pathol. 3, 1–8 (2020).

    Google Scholar 

  • Jin, K., Qian, C., Lin, J. & Liu, B. Cyclooxygenase-2-Prostaglandin E2 pathway: A key player in tumor-associated immune cells. Front. Oncol. 13, 1099811. https://doi.org/10.3389/fonc.2023.1099811 (2023).

    Google Scholar 

  • Xu, L. & Croix, B. S. Improving VEGF-targeted therapies through inhibition of COX-2/PGE2 signaling. Mol. Cell Oncol. 1, e969154. https://doi.org/10.4161/23723548.2014.969154 (2014).

    Google Scholar 

  • Shono, T., Tofilon, P. J., Bruner, J. M., Owolabi, O. & Lang, F. F. Cyclooxygenase-2 expression in human gliomas: Prognostic significance and molecular correlations. Cancer Res. 61, 4375–4381 (2001).

    Google Scholar 

  • Zhang, F., Chu, J. & Wang, F. Expression and clinical significance of cyclooxygenase 2 and survivin in human gliomas. Oncol. Lett. 14, 1303–1308. https://doi.org/10.3892/ol.2017.6281 (2017).

    Google Scholar 

  • Wang, X. et al. Co-expression of COX-2 and 5-LO in primary glioblastoma is associated with poor prognosis. J. Neurooncol. 125, 277–285. https://doi.org/10.1007/s11060-015-1919-6 (2015).

    Google Scholar 

  • Hicklin, D. J. & Ellis, L. M. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J. Clin. Oncol. 23, 1011–1027. https://doi.org/10.1200/jco.2005.06.081 (2005).

    Google Scholar 

  • Qiu, J., Shi, Z. & Jiang, J. Cyclooxygenase-2 in glioblastoma multiforme. Drug Discov. Today 22, 148–156. https://doi.org/10.1016/j.drudis.2016.09.017 (2017).

    Google Scholar 

  • Lu-Emerson, C. et al. Lessons from anti-vascular endothelial growth factor and anti-vascular endothelial growth factor receptor trials in patients with glioblastoma. J. Clin. Oncol. 33, 1197–1213. https://doi.org/10.1200/jco.2014.55.9575 (2015).

    Google Scholar 

  • Motomura, K. et al. Cost of medical care for malignant brain tumors at hospitals in the Japan clinical oncology group brain-tumor study group. Jpn. J. Clin. Oncol. 54, 1123–1131. https://doi.org/10.1093/jjco/hyae116 (2024).

    Google Scholar 

  • Hashemi Goradel, N., Najafi, M., Salehi, E., Farhood, B. & Mortezaee, K. Cyclooxygenase-2 in cancer: A review. J. Cell Physiol. 234, 5683–5699. https://doi.org/10.1002/jcp.27411 (2019).

    Google Scholar 

  • Lin, P. C., Lin, Y. J., Lee, C. T., Liu, H. S. & Lee, J. C. Cyclooxygenase-2 expression in the tumor environment is associated with poor prognosis in colorectal cancer patients. Oncol. Lett. 6, 733–739 (2013).

    Google Scholar 

  • Shi, C. et al. High COX-2 expression contributes to a poor prognosis through the inhibition of chemotherapy-induced senescence in nasopharyngeal carcinoma. Int. J. Oncol. 53, 1138–1148. https://doi.org/10.3892/ijo.2018.4462 (2018).

    Google Scholar 

  • Kambe, A. et al. The utility of arterial spin labeling imaging for predicting prognosis after a recurrence of high-grade glioma in patients under bevacizumab treatment. J. Neurooncol. 166, 175–183. https://doi.org/10.1007/s11060-023-04550-w (2024).

    Google Scholar 

  • Lombardi, F. et al. Cyclooxygenase-2 upregulated by temozolomide in glioblastoma cells is shuttled in extracellular vesicles modifying recipient cell phenotype. Front. Oncol. 12, 933746. https://doi.org/10.3389/fonc.2022.933746 (2022).

    Google Scholar 

  • Lombardi, F. et al. Up-regulation of cyclooxygenase-2 (COX-2) expression by temozolomide (TMZ) in human glioblastoma (GBM) cell lines. Int. J. Mol. Sci. https://doi.org/10.3390/ijms23031545 (2022).

    Google Scholar 

  • Schmainda, K. M. et al. Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma. Neuro Oncol. 16, 880–888. https://doi.org/10.1093/neuonc/not216 (2014).

    Google Scholar 

  • Leu, K. et al. Hypervascular tumor volume estimated by comparison to a large-scale cerebral blood volume radiographic atlas predicts survival in recurrent glioblastoma treated with bevacizumab. Cancer Imaging 14, 31. https://doi.org/10.1186/s40644-014-0031-z (2014).

    Google Scholar 

  • Kickingereder, P. et al. Relative cerebral blood volume is a potential predictive imaging biomarker of bevacizumab efficacy in recurrent glioblastoma. Neuro Oncol. 17, 1139–1147. https://doi.org/10.1093/neuonc/nov028 (2015).

    Google Scholar 

  • Liu, T. T. et al. Magnetic resonance perfusion image features uncover an angiogenic subgroup of glioblastoma patients with poor survival and better response to antiangiogenic treatment. Neuro Oncol. 19, 997–1007. https://doi.org/10.1093/neuonc/now270 (2017).

    Google Scholar 

  • Bennett, I. E. et al. Early perfusion MRI predicts survival outcome in patients with recurrent glioblastoma treated with bevacizumab and carboplatin. J. Neurooncol. 131, 321–329. https://doi.org/10.1007/s11060-016-2300-0 (2017).

    Google Scholar 

  • Schmainda, K. M. et al. Dynamic susceptibility contrast MRI measures of relative cerebral blood volume as a prognostic marker for overall survival in recurrent glioblastoma: Results from the ACRIN 6677/RTOG 0625 multicenter trial. Neuro Oncol. 17, 1148–1156. https://doi.org/10.1093/neuonc/nou364 (2015).

    Google Scholar 

  • Alves, B. et al. High VEGFA expression is associated with improved progression-free survival after bevacizumab treatment in recurrent glioblastoma. Cancers https://doi.org/10.3390/cancers15082196 (2023).

    Google Scholar 

  • Rawat, C. et al. Downregulation of peripheral PTGS2/COX-2 in response to valproate treatment in patients with epilepsy. Sci. Rep. 10, 2546. https://doi.org/10.1038/s41598-020-59259-x (2020).

    Google Scholar 

  • Est-Witte, S. E. et al. Non-viral gene delivery of HIF-1α promotes angiogenesis in human adipose-derived stem cells. Acta Biomater. 113, 279–288. https://doi.org/10.1016/j.actbio.2020.06.042 (2020).

    Google Scholar 

  • Wen, P. Y. et al. Updated response assessment criteria for high-grade gliomas: Response assessment in neuro-oncology working group. J. Clin. Oncol. 28, 1963–1972. https://doi.org/10.1200/jco.2009.26.3541 (2010).

    Google Scholar 

Continue Reading

  • PSL Sialkot franchise owner Hamza Majeed unveils vision, infrastructure plans and player strategy

    PSL Sialkot franchise owner Hamza Majeed unveils vision, infrastructure plans and player strategy

    Hamza Majid, owner of the newly awarded Pakistan Super League (PSL) franchise based in Sialkot, on Wednesday outlined his ambitious vision for the team, stressing long-term development, infrastructure investment, merit-based selection, and…

    Continue Reading

  • Scientists uncover a hidden aging program in the gut that fuels cancer risk

    Scientists uncover a hidden aging program in the gut that fuels cancer risk

    The human gut replaces its cells faster than any other tissue in the body. Every few days, fresh cells are produced by specialized stem cells that keep the intestinal lining healthy. Over time, however, these stem cells begin to accumulate…

    Continue Reading

  • Greenlanders ‘don’t want to be Americans’, say political leaders amid Trump threats | Greenland

    Greenlanders ‘don’t want to be Americans’, say political leaders amid Trump threats | Greenland

    Greenlanders “don’t want to be Americans” and must decide the future of the Arctic island themselves, politicians in the self-governing Danish territory have said, after Donald Trump warned the US would “do something whether they like it…

    Continue Reading

  • Cruz Beckham Revealed ‘Facts’ About Feud With Brooklyn as Legal Letter Sent

    Cruz Beckham has already revealed the facts about the Beckham family feud amid reports claiming Brooklyn has sent a legal letter to his parents.

    Brooklyn, 26, is the eldest son of former Manchester United star David Beckham and ex-Spice Girls…

    Continue Reading

  • No. 8 Maryland to Host No. 19 Ohio State in Blackout Game Sunday

    No. 8 Maryland to Host No. 19 Ohio State in Blackout Game Sunday

    #8/8 Maryland (16-1, 4-1) vs. No. 19/19 Ohio State (14-2, 4-1)

    January 11, 2026

    4 PM…

    Continue Reading